Peripheral Blood Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematologic NeoplasmsCombined Modality TherapyGranulocyte Colony-Stimulating FactorMelphalanBusulfanCyclophosphamideAntigens, CD34LeukapheresisGraft SurvivalStem Cell TransplantationBlood Component RemovalMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationTreatment OutcomeBone MarrowRecurrenceRemission InductionLymphoma, Non-HodgkinHematopoietic Stem CellsMyeloablative AgonistsTransplantation ChimeraTissue DonorsLeukemiaEtoposideAnemia, AplasticBone Marrow CellsThiotepaAntineoplastic Agents, AlkylatingHematopoiesisHistocompatibility TestingHistocompatibilityCarmustineCytarabineSalvage TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteDisease-Free SurvivalRetrospective StudiesTime FactorsCytophagocytosisTransplantation, IsogeneicImmunosuppressive AgentsSurvival AnalysisSurvival RateVincristineIfosfamideGraft vs Leukemia EffectHodgkin DiseaseStem CellsCord Blood Stem Cell TransplantationBone Marrow PurgingAmyloidosisInfectionLymphocyte DepletionGraft vs Tumor EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocyte TransfusionNeoplasmsMyelodysplastic SyndromesCytomegalovirus InfectionsFatal OutcomeFollow-Up StudiesT-LymphocytesLiver TransplantationImmunosuppressionAcute DiseaseLymphocyte TransfusionCyclosporinePrednisonePlatelet CountLymphomaLymphoma, T-CellDoxorubicinHLA AntigensHematologic DiseasesRecombinant ProteinsProspective StudiesTransplantation ImmunologyHepatic Veno-Occlusive DiseaseLeukemia, MyeloidNuclear FamilyPOEMS SyndromeBlood Cell CountBlood CellsVidarabineImmunophenotypingRadiation ChimeraCarboplatinAntineoplastic AgentsGraft vs Host ReactionDexamethasone